• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—July 2

    OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser

    Pancryos Forges License Agreement for Microencapsulation Device

    FDA Awards IDE Approval to SELUTION SLR Drug-Eluting Balloon

    Matt Rainville Joins Bigfoot Biomedical as Chief Commercial Officer
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Theranos Fraud Trial, Part II: The Blame Game Continues

    An Update on Surgical Robotics

    Letting the Light In: How Failure Analysis is the Cornerstone of Success

    Three Talent Strategies to Attract High-Demand Skills

    The Advantages of Bioburden Screening for Sterilization Validation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Concise Engineering

    BMP Medical

    Arthur G. Russell Co. Inc., The

    Cirtec Medical

    Trademark Plastics Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    ‘Right to Repair’: Separating Fact from Fiction

    Taking a Holistic Approach to Decentralized Clinical Trials (DCTs)

    Investment in Health Startups Drops

    The Power of Leveraging Customer Relationships

    Cost Effective & Efficient Wire EDM Techniques
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Concise Engineering

    BMP Medical

    Arthur G. Russell Co. Inc., The

    Cirtec Medical

    Trademark Plastics Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Intact Vascular Completes Enrollment in TOBA II Clinical Trial

    Trial studies the combination of the Tack Endovascular System with both standard and drug coated balloon angioplasty.

    Related CONTENT
    • Is Your Biocompatibility Program on the Edge?
    • New 510(k) Approach Would Leverage FDA Objective Criteria
    • FDA Clears CrossBay Medical's IVF Embryo Transfer Catheter Set
    • FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers
    • Industry Offers Support for Gottlieb Confirmation
    Business Wire04.05.17
    Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced that its Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial has completed enrollment. A total of 210 patients have been enrolled in TOBA II at 33 sites in the United States and Europe.
     
    The TOBA II trial is a prospective, multi-center, two-arm, non-randomized study designed to investigate the safety and efficacy of the Tack Endovascular System in combination with standard or drug coated balloon (DCB) angioplasty in the arteries above the knee. Target vessels include the superficial femoral artery (SFA) and the proximal segment of the popliteal artery. The Tack Endovascular System is a new technology designed to repair dissections (or tears) in artery walls that frequently occur as a complication of standard or DCB angioplasty. The system allows physicians to repair these dissections while leaving a minimal amount of foreign material in the artery, reducing mechanical stress on the artery, and preserving future treatment options.
     
    The design of TOBA II is unique in that it permits use of the Tack® system following either standard (uncoated) balloon angioplasty or drug coated balloon angioplasty using the BARD Lutonix DCB. Patients are enrolled in either group based upon the treating physician’s clinical judgement. The primary effectiveness endpoint for TOBA II is Duplex derived patency at 12-months following treatment.
     
    Dr. William Gray, system chief of the Main Line Health Cardiovascular Disease Division, is the national principal investigator for the TOBA II study. “TOBA II is a unique clinical study which will give us important insights into a new approach to dissection repair that holds great promise for advancing the endovascular treatment of peripheral artery disease," he said. "I extend my sincere appreciation and congratulations to all of the investigators and their teams for making the timely achievement of this milestone possible.”
     
    “The Tack Endovascular System was conceived as a minimal metal approach to dissection repair, and that idea has become even more important with the advent of drug coated balloon angioplasty. The completion of TOBA II enrollment is an exciting step toward FDA approval and ultimately making the Tack Endovascular System broadly available to patients suffering from peripheral arterial disease,” said Dr. Peter Schneider, a Honolulu (Hawaii) vascular surgeon and Intact Vascular’s co-founder and chief medical officer.
     
    Intact Vascular is also sponsoring the TOBA II BTK and TOBA III studies. TOBA II BTK is investigating the combination of the Tack Endovascular System with plain balloon angioplasty in the arteries below the knee. TOBA III is currently underway in Europe and is investigating the combination of the Tack Endovascular System with the Medtronic IN.PACT Admiral Drug-Coated Balloon.
     
    Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack Endovascular System is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral arterial disease. The firm is based in Wayne, Pa.
    Related Searches
    • medical device
    • medtronic
    • clinical study
    • standard
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Is Your Biocompatibility Program on the Edge? Is Your Biocompatibility Program on the Edge?
    New 510(k) Approach Would Leverage FDA Objective Criteria New 510(k) Approach Would Leverage FDA Objective Criteria
    FDA Clears CrossBay Medical FDA Clears CrossBay Medical's IVF Embryo Transfer Catheter Set
    FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers
    Industry Offers Support for Gottlieb Confirmation Industry Offers Support for Gottlieb Confirmation
    Intact Vascular Adds VP of Marketing and Business Development to Executive Management Team Intact Vascular Adds VP of Marketing and Business Development to Executive Management Team
    FDA Approves First First Flexible Shaver for Interventional Gastroenterology FDA Approves First First Flexible Shaver for Interventional Gastroenterology
    FDA Clears Samsung FDA Clears Samsung's Digital Radiography System
    FDA Designates Medtronic Action as Class I Recall FDA Designates Medtronic Action as Class I Recall
    Intact Vascular Begins Enrollment in Tack Optimized Balloon Angioplasty II BTK Trial Intact Vascular Begins Enrollment in Tack Optimized Balloon Angioplasty II BTK Trial
    Study Shows Benefit of Endovascular Intervention in Patients With Lower Extremity PAD Study Shows Benefit of Endovascular Intervention in Patients With Lower Extremity PAD
    Intact Vascular’s Tack Endovascular System Secures CE Mark for Repair of Dissections Intact Vascular’s Tack Endovascular System Secures CE Mark for Repair of Dissections
    Intact Vascular Closes on Additional Series B Funding Intact Vascular Closes on Additional Series B Funding

    Related Online Exclusives

    • Testing
      Is Your Biocompatibility Program on the Edge?

      Is Your Biocompatibility Program on the Edge?

      Regulatory changes in both Europe and the U.S. have created uncertainty among device makers.
      Thor Rollins, B.S., RN (NRCM), Senior Scientist, Nelson Laboratories 05.18.17

    • New 510(k) Approach Would Leverage FDA Objective Criteria

      New 510(k) Approach Would Leverage FDA Objective Criteria

      AdvaMed president issues statement in support of new legislation.
      Advanced Medical Technology Association 05.18.17

    • FDA Clears CrossBay Medical

      FDA Clears CrossBay Medical's IVF Embryo Transfer Catheter Set

      The device has also received clearance to commercialize the product in Europe by obtaining its CE mark.
      PR Newswire 05.18.17


    • Cardiovascular
      FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers

      FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers

      Portfolio of heart failure devices offers effective pacing and access to the most advanced diagnostic imaging procedures.
      Medtronic plc 05.11.17

    • Industry Offers Support for Gottlieb Confirmation

      Industry Offers Support for Gottlieb Confirmation

      Dr. Gottlieb previously served as the FDA’s deputy commissioner for medical and scientific affairs.
      Sean Fenske, Editor 05.10.17

    Loading, Please Wait..

    Trending
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • AI-Enabled SKOUT Device Improves Colorectal Cancer Screening
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • 7 Steps To Create Your Own Medical Device Marketing Plan
    Breaking News
    • MPO's Most-Read Stories This Week—July 2
    • OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser
    • Pancryos Forges License Agreement for Microencapsulation Device
    • FDA Awards IDE Approval to SELUTION SLR Drug-Eluting Balloon
    • Matt Rainville Joins Bigfoot Biomedical as Chief Commercial Officer
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • OEMs Seek Molders Offering Timely Techniques
    • Robotic Surgery: Cutting Through to the Latest
    • Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Pharmavite Expands in Ohio with $200 Million Investment
    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
    Coatings World

    Latest Breaking News From Coatings World

    Azelis Acquires Chemical Partners, Strengthens Leadership in Africa and Middle East
    Emmanuelle Bromet Named Arkema Sustainable Development VP
    ROSS Planetary Dual Dispersers Have Unique Processing Flexibility
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—July 2
    OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser
    Pancryos Forges License Agreement for Microencapsulation Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bayer Opens New Research and Innovation Center at Kendall Square
    Lonza Names Maria Soler Nunez as Head, Group Operations
    Eurofins DiscoverX Opens Shanghai Office
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Dexlevo Introduces Beauty Treatment technique, ‘GOURI’
    Revision Skincare Exec Wins Ernst & Young Entrepreneur of the Year
    Latest Updates About Cosmoprof North America
    Happi

    Latest Breaking News From Happi

    L’Oréal’s Solution for Gray Hair, Scotch Porter's New President & Boots No. 7 Beauty Is Not for Sale
    SCOTUS EPA Ruling Won’t Impact General Regulatory Authority
    Toning Collection For Zero-Brass Blondes is New at Colorproof
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Flint OPS, Xerox and MNYPIA Top This Week’s News
    Azelis Acquires Chemical Partners, Adds to Leadership in Africa and Middle East
    International Paper Publishes 2021 Sustainability Report
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    UPM Raflatac boosts operations in US, All4Labels returns to HP and more
    Fedrigoni Self-Adhesives to exhibit at Labelexpo Americas for first time
    CELAB Europe wins Paper Recycling award
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Lifetime Technical Achievement Award Presented to Richard Knowlson, Alkegen Completes Luyang Acquisition & More
    Glatfelter, Blue Ocean Closures Partner with Absolut
    What You’re Reading on Nonwovens-Industry.com
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—July 2
    NuVasive Inc. Opens Singapore Experience Center
    Pedicle Screw Systems Market to Top $3B in 2027
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: eMagin, Identiv, and Japan Display Top This Week’s Stories
    Epishine is Building a New Solar Cell Factory in Linköping, Sweden
    Toppan Establishes CVC Fund and Investment Management Company in the US

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login